Met Life Investment Management, LLC Prothena Corp Public LTD CO Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Met Life Investment Management, LLC holds 25,337 shares of PRTA stock, worth $377,014. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,337

Previous 25,337 -0.0%

Holding current value

$377,014

Previous $522,000 18.97%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$19.54 - $26.15 $68,096 - $91,132	3,485 Added 15.95%	25,337 $522,000
Q1 2024 May 14, 2024	BUY	$24.75 - $40.66 $540,837 - $888,502	21,852 New	21,852 $541,000
Q3 2023 May 09, 2024	BUY	$47.3 - $70.6 $61,584 - $91,921	1,302 Added 6.34%	21,852 $1.05 Million
Q2 2023 Apr 29, 2024	BUY	$48.26 - $78.59 $1.05 Million - $1.72 Million	21,852 New	21,852 $1.49 Million
Q2 2023 Aug 10, 2023	BUY	$48.26 - $78.59 $1.05 Million - $1.72 Million	21,852 New	21,852 $1.49 Million
Q1 2023 May 09, 2024	BUY	$46.97 - $58.27 $965,233 - $1.2 Million	20,550 New	20,550 $996 Million
Q4 2022 Jun 14, 2023	BUY	$52.05 - $65.0 $1.02 Million - $1.27 Million	19,561 New	19,561 $1.18 Billion
Q3 2022 Jun 14, 2023	BUY	$25.16 - $60.63 $492,154 - $1.19 Million	19,561 New	19,561 $1.19 Billion
Q2 2022 Jun 20, 2023	BUY	$22.73 - $39.98 $444,621 - $782,048	19,561 New	19,561 $531 Million
Q1 2022 May 10, 2024	BUY	$30.27 - $49.22 $592,111 - $962,792	19,561 New	19,561 $715,000
Q1 2022 Jun 20, 2023	BUY	$30.27 - $49.22 $592,111 - $962,792	19,561 New	19,561 $715 Million
Q4 2021 Jun 21, 2023	BUY	$42.11 - $73.26 $531,007 - $923,808	12,610 New	12,610 $623 Million
Q3 2021 Jun 21, 2023	BUY	$48.2 - $78.89 $607,802 - $994,802	12,610 New	12,610 $898 Million
Q1 2021 May 17, 2024	SELL	$11.0 - $28.24 $101,662 - $260,994	-9,242 Reduced 42.29%	12,610 $316,000
Q1 2021 Jun 26, 2023	BUY	$11.0 - $28.24 $138,710 - $356,106	12,610 New	12,610 $317 Million
Q4 2020 Jun 22, 2023	BUY	$10.12 - $13.94 $185,438 - $255,436	18,324 New	18,324 $220 Million
Q3 2020 Jun 26, 2023	BUY	$9.93 - $13.47 $181,957 - $246,824	18,324 New	18,324 $183 Million
Q2 2020 May 24, 2024	SELL	$9.56 - $12.51 $33,727 - $44,135	-3,528 Reduced 16.14%	18,324 $192 Million
Q2 2020 Jun 26, 2023	BUY	$9.56 - $12.51 $175,177 - $229,233	18,324 New	18,324 $192 Million
Q1 2020 Jul 12, 2023	BUY	$7.54 - $15.77 $138,162 - $288,969	18,324 New	18,324 $196 Million
Q4 2019 Jul 12, 2023	BUY	$7.48 - $17.01 $137,063 - $311,691	18,324 New	18,324 $290 Million
Q3 2019 Jul 12, 2023	BUY	$6.89 - $10.45 $126,252 - $191,485	18,324 New	18,324 $144 Million
Q2 2019 Jul 12, 2023	BUY	$8.85 - $12.49 $162,167 - $228,866	18,324 New	18,324 $194 Million
Q1 2019 Jul 13, 2023	BUY	$10.32 - $14.49 $189,103 - $265,514	18,324 New	18,324 $222 Million
Q4 2018 Jul 13, 2023	BUY	$8.73 - $13.74 $159,968 - $251,771	18,324 New	18,324 $189 Million
Q3 2018 Jul 13, 2023	BUY	$12.7 - $15.79 $232,714 - $289,335	18,324 New	18,324 $240 Million

Others Institutions Holding PRTA

# of Institutions

184

Shares Held

42.7M

Call Options Held

162K

Put Options Held

102K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $698M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Prothena Corp Public LTD CO Transaction History